Dorota Moroziewicz - Concepedia

Author

Dorota Moroziewicz

Also Known As

D. Moroziewicz, D. N. Moroziewicz, D.N. Moroziewicz, Dorota Moroziewicz, Dorota N Moroziewicz, Dorota N. Moroziewicz, Frederick J. Monsma, Katie Brenner

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Columbia University New York Stem Cell Foundation New York State Office for People With Developmental Disabilities Columbia University Irving Medical Center Albert Einstein College of Medicine

About

Dorota Moroziewicz is an author at Columbia University specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	695
2	Cell Biology	6	6	531
3	Immunology	3	3	243
4	Health Sciences	2	2	276
5	Natural Sciences	1	1	16

Dorota Moroziewicz

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization of CD4<sup>+</sup>CD25<sup>+</sup> Regulatory T Cells in Patients Treated With High-Dose Interleukin-2 for Metastatic Melanoma or Renal Cell Carcinoma G Cesana, Gail DeRaffele, Seth A. Cohen, Journal of Clinical Oncology	2006	346
Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells Daniel Paull, Ana Sevilla, Hongyan Zhou, Nature Methods Tissue EngineeringRegenerative MedicineInduced Pluripotent Stem CellDevelopmental BiologyHealth Sciences	2015	255
The lymphoid chemokine CCL21 costimulates naïve T cell expansion and Th1 polarization of non-regulatory CD4+ T cells Kenneth Flanagan, Dorota Moroziewicz, Heesun Kwak, Cellular Immunology Lymphoid Chemokine Ccl21T-regulatory CellImmunologyAutoimmunityT Cell Immunity	2004	138
Local Delivery of Vaccinia Virus Expressing Multiple Costimulatory Molecules for the Treatment of Established Tumors Howard L. Kaufman, Seth M. Cohen, Ken Cheung, Human Gene Therapy Synthetic VirologyViral ImmunityImmunologyImmunoeditingDirect Injection	2006	76
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma Howard L. Kaufman, Bret Taback, William H. Sherman, Journal of Translational Medicine	2009	74
Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting David J. Kahler, Faizzan S. Ahmad, A. Ritz, PLoS ONE	2013	58
Reevaluation of Neuronal Ceroid Lipofuscinoses: Atypical Juvenile Onset May Be the Result of CLN2 Mutations K. E. Wisniewski, A. Kaczmarski, E Kida, Molecular Genetics and Metabolism Neuro-oncologyDevelopmental BiologyNeuronal CeroidPathologyChoroid Plexus	1999	44
RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer Joseph DiNorcia, Minna K. Lee, Dorota Moroziewicz, Journal of Gastrointestinal Surgery Tumor BiologyPancreatic CancerMurine ModelPathologyRage Gene Deletion	2011	41
Heterogeneity of late-infantile neuronal ceroid lipofuscinosis Nanbert Zhong, Dorota Moroziewicz, Weina Ju, Genetics in Medicine Neuro-oncologyNeuroanatomyCerebrospinal FluidPathologyNeurology	2000	38
Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipoluscinosis Nan Zhong, Krystyna, Éva Wisniewski, Clinical Genetics	1998	37

Page 1